Pierre Boulud

Ipsen Pharma SA manufactures and distributes pharmaceutical products. It supplies products to the therapeutic areas such as oncology, endocrinology, and neuromuscular disorders. The firm also develops drugs for gastroenterology, cognitive disorders, and cardiovascular diseases. Ipsen Pharma is headquartered in Sant Feliu de Llobregat, Spain.

Biomérieux Diagnostic Product (Shanghai) Co., Ltd. engages in the distribution of medical diagnostic products. Its business scope includes warehousing, distribution, display, technical research, technical training, technical consultation, maintenance, and after-sales service of medical diagnostic reagents, medical equipment, and related parts in the bonded area; international trade, entrepot trade, inter-firm trade and trade agents of medical diagnostic reagents, medical equipment, and related parts in the bonded area; commercially simple processing in the bonded area; trade advisory services in the bonded area; and wholesale, commission agent, import and export, and other related supporting services for clinical laboratory analysis instruments and diagnostic reagents. The company was founded on January 4, 2005 and is headquartered in Shanghai, China.

Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France.